AbCellera Biologics Inc (ABCL)
2.825
-0.12
(-4.24%)
USD |
NASDAQ |
Nov 26, 16:00
2.825
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Price: 2.825 for Nov. 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 25, 2024 | 2.80 | 3.02 | 2.80 | 2.95 | 2.517M |
Nov 22, 2024 | 2.74 | 2.830 | 2.71 | 2.76 | 1.807M |
Nov 21, 2024 | 2.66 | 2.77 | 2.61 | 2.72 | 1.428M |
Nov 20, 2024 | 2.69 | 2.72 | 2.62 | 2.67 | 1.720M |
Nov 19, 2024 | 2.63 | 2.72 | 2.61 | 2.71 | 1.819M |
Nov 18, 2024 | 2.66 | 2.71 | 2.59 | 2.65 | 2.502M |
Nov 15, 2024 | 2.75 | 2.76 | 2.57 | 2.65 | 3.272M |
Nov 14, 2024 | 2.96 | 2.97 | 2.76 | 2.76 | 2.756M |
Nov 13, 2024 | 3.00 | 3.09 | 2.90 | 2.92 | 2.667M |
Nov 12, 2024 | 3.09 | 3.09 | 2.93 | 2.96 | 4.000M |
Nov 11, 2024 | 2.72 | 3.18 | 2.72 | 3.15 | 7.643M |
Nov 08, 2024 | 2.71 | 2.745 | 2.62 | 2.70 | 2.167M |
Nov 07, 2024 | 2.80 | 2.84 | 2.63 | 2.72 | 2.348M |
Nov 06, 2024 | 2.74 | 2.805 | 2.64 | 2.76 | 1.685M |
Nov 05, 2024 | 2.50 | 2.79 | 2.50 | 2.72 | 3.837M |
Nov 04, 2024 | 2.755 | 2.90 | 2.72 | 2.89 | 3.645M |
Nov 01, 2024 | 2.74 | 2.80 | 2.715 | 2.73 | 1.245M |
Oct 31, 2024 | 2.76 | 2.78 | 2.70 | 2.73 | 955267.0 |
Oct 30, 2024 | 2.83 | 2.89 | 2.78 | 2.78 | 1.230M |
Oct 29, 2024 | 2.86 | 2.890 | 2.77 | 2.83 | 1.154M |
Oct 28, 2024 | 2.75 | 2.905 | 2.74 | 2.89 | 2.851M |
Oct 25, 2024 | 2.70 | 2.86 | 2.70 | 2.72 | 2.302M |
Oct 24, 2024 | 2.80 | 2.840 | 2.64 | 2.70 | 3.255M |
Oct 23, 2024 | 2.81 | 2.829 | 2.725 | 2.78 | 1.115M |
Oct 22, 2024 | 2.78 | 2.84 | 2.744 | 2.84 | 1.213M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.39
Minimum
Sep 06 2024
58.90
Maximum
Dec 11 2020
12.00
Average
8.58
Median
Price Benchmarks
Aurinia Pharmaceuticals Inc | 8.70 |
Edesa Biotech Inc | 2.27 |
Lexaria Bioscience Corp | 2.11 |
InMed Pharmaceuticals Inc | 4.37 |
Xenon Pharmaceuticals Inc | 42.44 |
Price Related Metrics
PS Ratio | 25.12 |
PEG Ratio | -0.1302 |
Price to Book Value | 0.7740 |
Earnings Yield | -21.59% |
Market Cap | 834.41M |
PEGY Ratio | -0.1302 |